<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Brain-derived neurotrophic factor (BDNF) has been shown to be necessary and sufficient for post-<z:hpo ids='HP_0001297'>stroke</z:hpo> recovery in rodents </plain></SENT>
<SENT sid="1" pm="."><plain>From these observations, we and others have hypothesized that a common single nucleotide polymorphism (SNP) in the pro-domain of bdnf that leads to a methionine (Met) substitution for valine (Val) at codon 66 (Val66Met) will affect <z:hpo ids='HP_0001297'>stroke</z:hpo> outcome </plain></SENT>
<SENT sid="2" pm="."><plain>Here we investigate the effect of the BDNF genetic variant on ischemic outcome by using mice with a genetic knock-in of the human BDNF variant in both alleles (BDNF(Met/Met)) </plain></SENT>
<SENT sid="3" pm="."><plain>Compared with <z:mp ids='MP_0002169'>wild-type</z:mp> mice, BDNF(Met/Met) mice exhibited reduced <z:chebi fb="7" ids="29425,29426,29441,29447">CNS</z:chebi> BDNF levels without a discernable effect on <z:mpath ids='MPATH_124'>infarct</z:mpath> size </plain></SENT>
<SENT sid="4" pm="."><plain>Diminished BDNF levels in BDNF(Met/Met) mice were associated with greater deficits in post-<z:hpo ids='HP_0001297'>stroke</z:hpo> locomotor functions </plain></SENT>
<SENT sid="5" pm="."><plain>Additionally, the BDNF(Met/Met) mice showed <z:mp ids='MP_0005602'>reduced angiogenesis</z:mp> and elevated expression of thrombospondin-1 (TSP-1) and its receptor CD36, anti-angiogenic factors </plain></SENT>
<SENT sid="6" pm="."><plain>To assess the functional role of CD36 in antagonizing angiogenic response in Met homozygosity at the BDNF locus, we crossed BDNF(Met/Met) mice with CD36 knock-out mice </plain></SENT>
<SENT sid="7" pm="."><plain>The double-mutant mice rescued the angiogenic deficit associated with the BDNF(Met/Met) mice without alterations in BDNF levels, indicating that the behavioral deficit in BDNF(Met/Met) mice after <z:hpo ids='HP_0001297'>stroke</z:hpo> is partly related to an unfavorable balance in pro-angiogenic BDNF and anti-angiogenic TSP-1/CD36 </plain></SENT>
<SENT sid="8" pm="."><plain>The results suggest that CD36 inhibition may be a viable strategy to enhance <z:mpath ids='MPATH_177'>angiogenesis</z:mpath> and possible recovery in human <z:hpo ids='HP_0001297'>stroke</z:hpo> victims who are Met homozygotes at codon 66 of the BDNF locus </plain></SENT>
</text></document>